Pneumonic Plague: Definitive Treatment Regimen

Bolded Recommendation

Start immediate IV therapy with a first-line fluoroquinolone (levofloxacin 750 mg IV q24h or ciprofloxacin 400 mg IV q8h) for 10–14 days; if severe disease or suspected bioterrorism exposure, begin dual therapy with two different classes (e.g., levofloxacin plus gentamicin 5 mg/kg IV/IM q24h). 1

Rationale prioritized for mortality, morbidity, and QOL

2021 CDC/US HHS guideline (highest-quality, most recent) recommends fluoroquinolones, doxycycline, or aminoglycosides as first-line; duration 10–14 days; dual therapy for severe pneumonic/septicemic disease or intentional release scenarios to reduce mortality risk 1.
Animal-rule data show >90% survival with ciprofloxacin/levofloxacin, gentamicin effective but less consistent, doxycycline less effective—supporting fluoroquinolone-first to maximize survival/QOL 2.

First-line monotherapy (naturally acquired, not critically ill):
- Levofloxacin 750 mg IV/PO q24h OR ciprofloxacin 400 mg IV q8h (750 mg PO q12h when stable) for 10–14 days 1.
- Alternatives: moxifloxacin 400 mg IV/PO q24h; doxycycline 200 mg load, then 100 mg IV/PO q12h; gentamicin 5 mg/kg IV/IM q24h; streptomycin 1 g IV/IM q12h (availability issues) 1.
Severe pneumonic plague, septic shock/ARDS, or suspected intentional release:
- Dual therapy from different classes for initial treatment:
  - Levofloxacin 750 mg IV q24h PLUS gentamicin 5 mg/kg IV/IM q24h (preferred), then de-escalate to monotherapy once stabilized; total 10–14 days 1.

First-line (10–14 days) [weight-based per guideline]:
- Ciprofloxacin 10 mg/kg IV q8–12h or 15 mg/kg PO q8–12h (max 400 mg IV dose; 500 mg q8h or 750 mg q12h PO) OR
- Levofloxacin: <50 kg 8 mg/kg q12h; ≥50 kg 500–750 mg q24h IV/PO OR
- Doxycycline: <45 kg 4.4 mg/kg load then 2.2 mg/kg q12h; ≥45 kg adult dosing OR
- Gentamicin 4.5–7.5 mg/kg IV/IM q24h; Streptomycin 15 mg/kg q12h (max 1 g/dose) 1.
Severe/intentional release: use dual therapy initially (e.g., levofloxacin plus gentamicin) 1.

Meningitis suspected: add chloramphenicol; if unavailable, add moxifloxacin or levofloxacin to existing regimen; continue entire regimen an additional 10 days after add-on 1.
Transition to oral therapy when clinically improved and able to tolerate PO; complete total 10–14 days 1.

Immediate action: isolate, start empiric IV levofloxacin 750 mg q24h (or ciprofloxacin 400 mg q8h). If severe/biothreat, add gentamicin 5 mg/kg q24h. 1
Supportive care: early ICU if hypoxemia/shock; avoid beta-lactams (inferior, potential harm in late disease) 3.
Reassess at 24–48 h: if improving, continue; step down to PO fluoroquinolone when stable; complete 10–14 days. 1
Contacts: offer post-exposure prophylaxis per guideline (not detailed here). 1

Delay in antibiotics markedly increases mortality—treat immediately on suspicion. 1
Do not use beta-lactams for pneumonic plague (poor outcomes, possible accelerated mortality in models). 3
Streptomycin availability is limited; prefer levofloxacin/ciprofloxacin or gentamicin when needed. Monitor aminoglycoside toxicity. 1
In children, fluoroquinolones and doxycycline are acceptable in this life-threatening context; dose carefully. 1

Guideline (CDC/HHS 2021) is the primary, most recent, high-quality source guiding regimen and duration, including dual therapy indications 1.
Animal-rule studies underpin survival benefits: fluoroquinolones >90% efficacy; gentamicin effective; doxycycline less effective—aligns with choosing a fluoroquinolone first to optimize survival/QOL 2.